Liu Xiaolong, Li Xuran, Wu Guangyuan, Qi Pengfei, Zhang Yanyan, Liu Zhiyu, Li Xinyue, Yu Yu, Ye Xiangmei, Li Yang, Yang Dongguang, Teng Yueqiu, Shi Ce, Jin Xin, Qi Sen, Liu Yuting, Wang Shudan, Liu Ying, Cao Fenglin, Kong Qingran, Wang Zhenkun, Zhang Hong
Central Laboratory, First Affiliated Hospital, Harbin Medical University, Harbin, China.
College of Life Science, Northeast Agricultural University, Harbin, China.
Stem Cells Int. 2022 Jul 14;2022:1252557. doi: 10.1155/2022/1252557. eCollection 2022.
Rapid restoration of corneal epithelium integrity after injury is particularly important for preserving corneal transparency and vision. Mesenchymal stem cells (MSCs) can be taken into account as the promising regenerative therapeutics for improvement of wound healing processes based on the variety of the effective components. The extracellular vesicles form MSCs, especially exosomes, have been considered as important paracrine mediators though transferring microRNAs into recipient cell. This study investigated the mechanism of human umbilical cord MSC-derived small extracellular vesicles (HUMSC-sEVs) on corneal epithelial wound healing.
HUMSC-sEVs were identified by transmission electron microscopy, nanoparticle tracking analysis, and Western blot. Corneal fluorescein staining and histological staining were evaluated in a corneal mechanical wound model. Changes in HCEC proliferation after HUMSC-sEVs or miR-21 mimic treatment were evaluated by CCK-8 and EdU assays, while migration was assessed by in vitro scratch wound assay. Full-length transcriptome sequencing was performed to identify the differentially expressed genes associated with HUMSC-sEVs treatment, followed by validation via real-time PCR and Western blot.
The sEVs derived from HUMSCs can significantly promote corneal epithelial cell proliferation, migration in vitro, and corneal epithelial wound healing in vivo. Similar effects were obtained after miR-21 transfection, while the beneficial effects of HUMSC-sEVs were partially negated by miR-21 knockdown. Results also show that the benefits are associated with decreased PTEN level and activated the PI3K/Akt signaling pathway in HCECs.
HUMSC-sEVs could enhance the recovery of corneal epithelial wounds though restraining PTEN by transferring miR-21 and may represent a promising novel therapeutic agent for corneal wound repair.
损伤后角膜上皮完整性的快速恢复对于维持角膜透明度和视力尤为重要。基于多种有效成分,间充质干细胞(MSCs)可被视为改善伤口愈合过程的有前景的再生治疗方法。间充质干细胞来源的细胞外囊泡,尤其是外泌体,通过将微小RNA转移到受体细胞中,被认为是重要的旁分泌介质。本研究探讨了人脐带间充质干细胞来源的小细胞外囊泡(HUMSC-sEVs)对角膜上皮伤口愈合的作用机制。
通过透射电子显微镜、纳米颗粒跟踪分析和蛋白质免疫印迹法鉴定HUMSC-sEVs。在角膜机械性伤口模型中评估角膜荧光素染色和组织学染色。通过CCK-8和EdU试验评估HUMSC-sEVs或miR-21模拟物处理后角膜上皮细胞(HCEC)增殖的变化,同时通过体外划痕试验评估迁移情况。进行全长转录组测序以鉴定与HUMSC-sEVs处理相关的差异表达基因,随后通过实时聚合酶链反应和蛋白质免疫印迹法进行验证。
HUMSCs来源的sEVs可显著促进体外角膜上皮细胞增殖、迁移以及体内角膜上皮伤口愈合。miR-21转染后获得了类似的效果,而miR-21敲低部分抵消了HUMSC-sEVs的有益作用。结果还表明,这些益处与HCECs中PTEN水平降低和PI3K/Akt信号通路激活有关。
HUMSC-sEVs可通过转移miR-21抑制PTEN来促进角膜上皮伤口的恢复,可能是一种有前景的角膜伤口修复新型治疗药物。